{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:05:55Z","timestamp":1783991155344,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-156306"],"award-info":[{"award-number":["PJT-156306"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52706-1","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:14:40Z","timestamp":1778735680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between the T allele in rs204076 and treatment retention in patients receiving medication for opioid use disorder"],"prefix":"10.1038","volume":"16","author":[{"given":"Alannah","family":"McEvoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myanca","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"52706_CR1","unstructured":"The Government of Canada. Opioid- and Stimulant-related Harms in Canada, (2025)."},{"issue":"1","key":"52706_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-017-0130-5","volume":"12","author":"KA Morin","year":"2017","unstructured":"Morin, K. A., Eibl, J. K., Franklyn, A. M. & Marsh, D. C. The opioid crisis: Past, present and future policy climate in Ontario, Canada. Subst. Abuse Treat. Prev. Policy 12(1), 1\u20137 (2017).","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"issue":"7","key":"52706_CR3","first-page":"416","volume":"100","author":"D Coffa","year":"2019","unstructured":"Coffa, D. & Snyder, H. Opioid use disorder: Medical treatment options. Am. Fam. Physician 100(7), 416\u2013425 (2019).","journal-title":"Am. Fam. Physician"},{"key":"52706_CR4","unstructured":"Organization, W. H. Opioid overdose, [Online]. (2021). Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/opioid-overdose"},{"issue":"5","key":"52706_CR5","first-page":"347","volume":"67","author":"H Joseph","year":"2000","unstructured":"Joseph, H., Stancliff, S. & Langrod, J. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mt. Sinai J. Med. 67(5), 347\u2013364 (2000).","journal-title":"Mt. Sinai J. Med."},{"issue":"4","key":"52706_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","volume":"93","author":"LA Marsch","year":"1998","unstructured":"Marsch, L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 93(4), 515\u2013532 (1998).","journal-title":"Addiction"},{"issue":"14","key":"52706_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"CB Eap","year":"2002","unstructured":"Eap, C. B., Buclin, T. & Baumann, P. Interindividual variability of the clinical pharmacokinetics of methadone. Clin. Pharmacokinet. 41(14), 1153\u20131193 (2002).","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"52706_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","volume":"87","author":"J Bell","year":"2020","unstructured":"Bell, J. & Strang, J. Medication treatment of opioid use disorder. Biol. Psychiatry 87(1), 82\u201388 (2020).","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"52706_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","volume":"33","author":"M Shulman","year":"2019","unstructured":"Shulman, M., Wai, J. M. & Nunes, E. V. Buprenorphine treatment for opioid use disorder: An overview. CNS. Drugs 33(6), 567\u2013580 (2019).","journal-title":"CNS. Drugs"},{"issue":"7","key":"52706_CR10","doi-asserted-by":"publisher","first-page":"e2518389","DOI":"10.1001\/jamanetworkopen.2025.18389","volume":"8","author":"RA Kleinman","year":"2025","unstructured":"Kleinman, R. A. & Kurdyak, P. Duration of methadone and buprenorphine-naloxone treatment. JAMA Netw. Open 8(7), e2518389\u2013e2518389 (2025).","journal-title":"JAMA Netw. Open"},{"issue":"21","key":"52706_CR11","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1001\/jama.2024.16954","volume":"332","author":"B Nosyk","year":"2024","unstructured":"Nosyk, B. et al. Buprenorphine\/naloxone vs methadone for the treatment of opioid use disorder. JAMA 332(21), 1822\u20131831 (2024).","journal-title":"JAMA"},{"issue":"6","key":"52706_CR12","doi-asserted-by":"publisher","first-page":"e2518452","DOI":"10.1001\/jamanetworkopen.2025.18452","volume":"8","author":"A Holton","year":"2025","unstructured":"Holton, A. et al. Retention in opioid agonist therapy among First Nations people. JAMA Netw. Open. 8 (6), e2518452\u2013e2518452 (2025).","journal-title":"JAMA Netw. Open."},{"key":"52706_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110903","volume":"250","author":"E Peles","year":"2023","unstructured":"Peles, E., Kim, Y., Sason, A., Adelson, M. & Levran, O. Predictors of treatment retention and survival among methadone-maintained patients: A possible role for a functional delta opioid receptor gene variant. Drug Alcohol Depend. 250, 110903 (2023).","journal-title":"Drug Alcohol Depend."},{"issue":"2\u20133","key":"52706_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","volume":"107","author":"E Peles","year":"2010","unstructured":"Peles, E., Schreiber, S. & Adelson, M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend. 107(2\u20133), 141\u2013148 (2010).","journal-title":"Drug Alcohol Depend."},{"key":"52706_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2017.11.034","volume":"185","author":"E Peles","year":"2018","unstructured":"Peles, E., Schreiber, S., Sason, A. & Adelson, M. Similarities and changes between 15-and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center. Drug Alcohol Depend. 185, 112\u2013119 (2018).","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"52706_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/ajad.13268","volume":"31","author":"MM Sweeney","year":"2022","unstructured":"Sweeney, M. M. et al. Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting. Am. J. Addict. 31(3), 256\u2013260 (2022).","journal-title":"Am. J. Addict."},{"issue":"6","key":"52706_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/ajad.12414","volume":"25","author":"DE Marcovitz","year":"2016","unstructured":"Marcovitz, D. E., McHugh, R. K., Volpe, J., Votaw, V. & Connery, H. S. Predictors of early dropout in outpatient buprenorphine\/naloxone treatment. Am. J. Addict. 25(6), 472\u2013477 (2016).","journal-title":"Am. J. Addict."},{"issue":"D1","key":"52706_CR18","first-page":"D682","volume":"48","author":"AD Yates","year":"2020","unstructured":"Yates, A. D. et al. Ensembl 2020. Nucleic Acids Res. 48(D1), D682\u2013D688 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"52706_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1101\/gr.9.8.677","volume":"9","author":"ST Sherry","year":"1999","unstructured":"Sherry, S. T., Ward, M. & Sirotkin, K. dbSNP\u2014Database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 9(8), 677\u2013679 (1999).","journal-title":"Genome Res."},{"key":"52706_CR20","doi-asserted-by":"crossref","unstructured":"Von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med. 4(10), p.e296. (2007).","DOI":"10.1371\/journal.pmed.0040296"},{"key":"52706_CR21","doi-asserted-by":"crossref","unstructured":"Marsden, J. et al. The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome. Addiction, 93(12), 1857\u20131867 (2002).","DOI":"10.1046\/j.1360-0443.1998.9312185711.x"},{"key":"52706_CR22","unstructured":"Ltd, T. S. N. FaStep Assay. [Online]. Available: https:\/\/www.trimedic-inc.com\/wp-content\/uploads\/2018\/04\/Fastep-Package-Insert.pdf"},{"key":"52706_CR23","unstructured":"Centre d\u2019expertise et de services G\u00e9nome Qu\u00e9bec. [Online]. Available: https:\/\/cesgq.com\/"},{"key":"52706_CR24","unstructured":"illumina & GenomeStudio [Online]. (2022). Available: https:\/\/support.illumina.com\/array\/array_software\/genomestudio\/downloads.html"},{"key":"52706_CR25","unstructured":"illumina Infinium Global Screening Array\u2009\u2013\u200924 v1.0, [Online]. (2017). Available: https:\/\/grcf.jhmi.edu\/wp-content\/uploads\/2017\/12\/infinium-commercial-gsa-data-sheet-370-2016-016.pdf"},{"issue":"3","key":"52706_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81 (3), 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"52706_CR27","doi-asserted-by":"publisher","first-page":"s13742","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience 4(1), s13742-015 (2015).","journal-title":"Gigascience"},{"key":"52706_CR28","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2013","unstructured":"R Core Team. R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2013)."},{"issue":"11","key":"52706_CR29","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","volume":"48","author":"PR Loh","year":"2016","unstructured":"Loh, P. R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48 (11), 1443 (2016).","journal-title":"Nat. Genet."},{"issue":"10","key":"52706_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48(10), 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"52706_CR31","unstructured":"TOPMed TOPMed Imputation Server - Reference Panels. [Online]. Available: https:\/\/topmedimpute.readthedocs.io\/en\/latest\/reference-panels.html"},{"issue":"7845","key":"52706_CR32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590 (7845), 290\u2013299 (2021).","journal-title":"Nature"},{"issue":"7","key":"52706_CR33","doi-asserted-by":"publisher","first-page":"e0289059","DOI":"10.1371\/journal.pone.0289059","volume":"18","author":"A Hillmer","year":"2023","unstructured":"Hillmer, A. et al. Genetics of cannabis use in opioid use disorder: A Polygenic Risk Score and Genome-Wide Association Study. PLoS One. 18 (7), e0289059 (2023).","journal-title":"PLoS One"},{"issue":"3","key":"52706_CR34","first-page":"200","volume":"63","author":"A Srivastava","year":"2017","unstructured":"Srivastava, A., Kahan, M. & Nader, M. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?. Can. Fam. Physician 63(3), 200\u2013205 (2017).","journal-title":"Can. Fam. Physician"},{"issue":"1 CC-Drugs and","key":"52706_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/add.12333","volume":"109","author":"YI Hser","year":"2014","unstructured":"Hser, Y. I. et al. Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial. Addiction 109(1 CC-Drugs and Alcohol), 79\u201387 (2014).","journal-title":"Addiction"},{"issue":"2","key":"52706_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/08897077.2013.819828","volume":"35","author":"MI Fingerhood","year":"2014","unstructured":"Fingerhood, M. I., King, V. L., Brooner, R. K. & Rastegar, D. A. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment. Subst. Abus. 35(2), 122\u2013126 (2014).","journal-title":"Subst. Abus."},{"key":"52706_CR37","doi-asserted-by":"crossref","unstructured":"Degenhardt, L. et al. Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry 10(6), 386\u2013402 (2023).","DOI":"10.1016\/S2215-0366(23)00095-0"},{"issue":"4","key":"52706_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jsat.2011.09.013","volume":"42","author":"SE Zemore","year":"2012","unstructured":"Zemore, S. E. The effect of social desirability on reported motivation, substance use severity, and treatment attendance. J. Subst. Abuse Treat. 42(4), 400\u2013412 (2012).","journal-title":"J. Subst. Abuse Treat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52706-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:51:40Z","timestamp":1783990300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52706-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52706"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52706-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22012"}}